Incannex Healthcare Limited

Incannex Healthcare Limitedverified

IXHL

Price:

$1.66

Market Cap:

$29.29M

Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's products include IHL-42X, which is in Phase II clinical trials for obstructive sleep apnea; IHL-216A for traumatic brain injury; and IHL-675A, a combination of hydroxychloroquine and cannabidiol for the prevention and treatment of inflammatory lung conditions, such as acute respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, and bronchitis, as well as rheumatoid arthritis and inflammatory bowel diseases. It has partnership with The Alfred Hospital an...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2022-03-02

Stock Exchange

NASDAQ

Ticker

IXHL

The Enterprise Value as of September 2024 (TTM) for Incannex Healthcare Limited (IXHL) is 20.39M

According to Incannex Healthcare Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 20.39M. This represents a change of -36.11% compared to the average of 31.91M of the last 4 quarters.

Incannex Healthcare Limited (IXHL) Historical Enterprise Value (quarterly & annually)

How has IXHL Enterprise Value performed in the past?

The mean historical Enterprise Value of Incannex Healthcare Limited over the last ten years is 119.17M. The current 20.39M Enterprise Value has changed 1.61% with respect to the historical average. Over the past ten years (40 quarters), IXHL's Enterprise Value was at its highest in in the December 2023 quarter at 59.57M. The Enterprise Value was at its lowest in in the December 2021 quarter at -19770505.00.

Quarterly (TTM)
Annual

Average

119.17M

Median

82.67M

Minimum

20.87M

Maximum

382.21M

Incannex Healthcare Limited (IXHL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Incannex Healthcare Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 96.59%

Maximum Annual Enterprise Value = 382.21M

Minimum Annual Increase = -77.48%

Minimum Annual Enterprise Value = 20.87M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202320.87M-48.84%
202240.80M-77.48%
2021181.15M28.86%
2020140.57M-63.22%
2019382.21M90.09%
2018201.07M83.47%
2017109.59M96.59%
201655.75M45.82%
201538.23M77.80%
201421.50M5.98%

Incannex Healthcare Limited (IXHL) Average Enterprise Value

How has IXHL Enterprise Value performed in the past?

The current Enterprise Value of Incannex Healthcare Limited (IXHL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

80.94M

5-year avg

153.12M

10-year avg

119.17M

Incannex Healthcare Limited (IXHL) Enterprise Value vs. Peers

How is IXHL’s Enterprise Value compared to its peers?

Incannex Healthcare Limited’s Enterprise Value is less than Delta 9 Cannabis Inc. (65.36M), less than RAMM Pharma Corp. (0), greater than City View Green Holdings Inc. (3.35M), greater than Craftport Cannabis Corp. (10.04M), greater than Speakeasy Cannabis Club Ltd. (1.75M), less than Eagle Pharmaceuticals, Inc. (110.03M), less than ANI Pharmaceuticals, Inc. (1.34B), less than Phibro Animal Health Corporation (1.24B), less than Deciphera Pharmaceuticals, Inc. (2.15B), less than Prestige Consumer Healthcare Inc. (4.75B), less than Collegium Pharmaceutical, Inc. (1.58B), less than Silver Spike Investment Corp. (38.06M), less than Regencell Bioscience Holdings Limited (85.96M), less than Procaps Group S.A. (491.27M), less than Sihuan Pharmaceutical Holdings Group Ltd. (201.27M),

Build a custom stock screener for Incannex Healthcare Limited (IXHL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Incannex Healthcare Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Incannex Healthcare Limited (IXHL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Incannex Healthcare Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Incannex Healthcare Limited's Enterprise Value?

What is the highest Enterprise Value for Incannex Healthcare Limited (IXHL)?

What is the 3-year average Enterprise Value for Incannex Healthcare Limited (IXHL)?

What is the 5-year average Enterprise Value for Incannex Healthcare Limited (IXHL)?

How does the current Enterprise Value for Incannex Healthcare Limited (IXHL) compare to its historical average?